...
首页> 外文期刊>Journal of atherosclerosis and thrombosis. >Comparison of Food and Nutrient Intakes between Japanese Dyslipidemic Patients with and without Low-Density Lipoprotein Cholesterol Lowering Drug Therapy: A Cross-Sectional Study
【24h】

Comparison of Food and Nutrient Intakes between Japanese Dyslipidemic Patients with and without Low-Density Lipoprotein Cholesterol Lowering Drug Therapy: A Cross-Sectional Study

机译:日本渗透性患者食物和营养摄入量的比较,无低密脂蛋白胆固醇降低药物治疗:横截面研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Aim: We aimed to clarify actual food and nutrient intakes in Japanese patients with dyslipidemia. We also compared food and nutrient intakes between patients with and without low-density lipoprotein cholesterol (LDL-C) lowering drug therapy. Methods: Food and nutrient intakes were assessed employing 3-day weighted dietary records in this cross-sectional study of 104 Japanese outpatients with dyslipidemia, age 30-65 years, not given dietary counseling. Anthropometric and biochemical parameters were measured after an overnight fast. Food and nutrient intakes were compared between patients with versus without LDL-C lowering drug prescriptions. Stepwise multiple regression analysis was performed to identify relationships between the serum LDL-C concentrations and food intakes. Results: Of the 104 patients, 43.3% were prescribed LDL-C lowering drugs, primarily statins. Of the total patients, 83% had lipid intakes over 25% of total energy consumption (%E), exceeding the recommendation for dyslipidemia by the Japan Atherosclerosis Society. Similarly, 77% had saturated fatty acid intakes over 7%E, and 88% had cholesterol intakes over 200 mg per day. Dietary fiber consumption was low (<25 g) in 97% of patients. Those taking LDL-C lowering drugs consumed less “meat, poultry and processed meat products” and “cereals”, and more “fish”, “fruits” and “nuts”, than patients not taking these drugs ( p <0.05). Food intakes correlating with LDL-C concentrations independently of drug therapy differed between patients taking versus not taking these medications. Conclusion: Our results support the necessity of diet therapy for patients with dyslipidemia regardless of whether LDL-C lowering drugs are prescribed.
机译:目的:我们旨在澄清日本血脂血症患者的实际食物和营养摄入量。我们还比较了患有和不含低密度脂蛋白胆固醇(LDL-C)降低药物治疗的患者的食物和营养摄入量。方法:评估食品和营养摄入量,在这项横断面研究中使用3天加权膳食记录,对104例日本门诊患者的腹腔呆症,30-65岁,未给予膳食咨询。在快速过夜后测量人类测量和生化参数。在没有LDL-C降低药物处方的患者之间比较食物和营养摄入量。逐步进行多元回归分析以鉴定血清LDL-C浓度与食物摄入量之间的关系。结果:104例患者中,43.3%规定的LDL-C降低药物,主要是他汀类药物。在总患者中,83%的脂质摄入量超过了总能耗的25%(%e),超过了日本动脉粥样硬化协会的血脂血症的推荐。同样,77%的饱和脂肪酸摄入量超过7%E,88%的胆固醇摄入量超过200毫克。 97%的患者中膳食纤维消耗量低(<25克)。服用LDL-C降低药物的人消耗了较少的“肉,家禽和加工肉类产品”和“谷物”,以及更多“鱼”,“水果”和“坚果”,而不是未服用这些药物的患者(P <0.05)。食物摄入与LDL-C浓度与药物治疗的相关性相关,患者与未服用这些药物的患者之间不同。结论:我们的结果支持患有血脂血症患者的饮食治疗,无论是否规定了LDL-C降低药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号